Today's Information |
Provided by: SciVision Biotech Inc. | |||||
SEQ_NO | 1 | Date of announcement | 2022/08/11 | Time of announcement | 17:29:32 |
Subject | Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months | ||||
Date of events | 2022/08/11 | To which item it meets | paragraph 51 | ||
Statement | 1.Date of occurrence of the event:2022/08/11 2.Company name:SciVision Biotech Inc. 3.Relationship to the Company (please enter "head office" or "subsidiaries"):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:(1)The Company applied for extending the second domestic unsecured convertible bonds each with a par value of NTD 100,000, for a total amount of NTD 400,000,000.This application was approved by the Financial Supervisory Commission per May 27, 2022 letter No.1110343177. (2)On consideration of bigger fluctuation for domestic stock market and better issuance timing, and following the board resolution on May 03,2022 regarding authorizing chairman to do revision when conducting the issuance of domestic second unsecured convertible corporate bond responding to the change of objective environment. 6.Countermeasures:To make application to FSC to extend raising period for 3 months to find the most optimized issuance timing to protect the whole interests of the Company and shareholder equity. 7.Any other matters that need to be specified:None |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
SciVision Biotech Inc. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 09:40:08 UTC.